Australia markets closed

Calidi Biotherapeutics, Inc. (CLDI)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.2481+0.0206 (+9.05%)
At close: 03:56PM EDT
0.2500 +0.00 (+0.77%)
Pre-market: 05:22AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
45
449
0
Cost of revenue
-
0
14
94
0
Gross profit
-
0
31
355
0
Operating expenses
Research development
13,129
13,008
7,257
4,674
3,182
Selling general and administrative
17,201
15,984
15,902
6,163
3,591
Total operating expenses
28,136
26,107
23,159
10,837
6,773
Operating income or loss
-28,136
-26,107
-23,128
-10,482
-6,773
Interest expense
1,105
1,069
158
614
163
Total other income/expenses net
1,958
656
-2,130
174
-997
Income before tax
-29,963
-29,200
-25,416
-10,922
-7,933
Income tax expense
16
16
11
11
4
Income from continuing operations
-29,979
-29,216
-25,427
-10,933
-7,937
Net income
-29,979
-29,216
-25,427
-10,933
-7,937
Net income available to common shareholders
-29,979
-29,216
-25,427
-10,933
-7,937
Basic EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Diluted EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Basic average shares
35,907
16,887
35,907
35,907
35,907
Diluted average shares
35,907
16,887
35,907
35,907
35,907